<DOC>
	<DOCNO>NCT02509078</DOCNO>
	<brief_summary>This study evaluate whether give neuromuscular blocker ( skeletal muscle relaxant ) patient acute respiratory distress syndrome improve survival . Half patient receive neuromuscular blocker two day half use neuromuscular blocker discourage .</brief_summary>
	<brief_title>Reevaluation Of Systemic Early Neuromuscular Blockade</brief_title>
	<detailed_description>PRIMARY OBJECTIVE : : To assess efficacy safety early neuromuscular blockade reduce mortality morbidity patient moderate-severe ARDS , comparison control group routine early neuromuscular blockade ( NMB ) . PRIMARY HYPOTHESIS : Early neuromuscular blockade improve mortality prior discharge home day 90 , patient moderate-severe ARDS . The trial accrue maximum 1408 patient . Patients recruit emergency department , intensive care unit acute care area PETAL Network Clinical Centers randomize active ( NMB ) control . The overall strategy screen , consent , enroll early , every newly intubate , acutely ill post-operative , eligible patient site , use clinically obtain pulse oximetry blood gas . By prevent active expiration , and/or patient ventilator dyssynchrony , neuromuscular blockade may create homogenous distribution airway pressure tidal volume , prevent barotrauma/volutrauma `` atelectrauma '' result less ventilator-induced lung injury .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>Inclusion Criteria 1 . Age &gt; 18 year 2 . Presence follow condition &lt; 48 hour : i. PaO2/FiO2 &lt; 150 PEEP &gt; /= 8 cm H2O OR , ABG available , SaO2/FiO2 ratio equivalent PaO2/FiO2 &lt; 150 PEEP &gt; /= 8 cm H2O , confirmatory SaO2/FiO2 ratio equivalent 16 hour later ii . Bilateral opacities fully explain effusion , lobar/lung collapse , nodule . iii . Respiratory failure fully explain cardiac failure fluid overload ; need objective assessment ( e.g. , echocardiography ) exclude hydrostatic edema risk factor present . Patients must enrol within 48 hour meet inclusion criterion . 1 . Lack inform consent 2 . Continuous neuromuscular blockade enrollment 3 . Known pregnancy 4 . Currently receive ECMO therapy 5 . Chronic respiratory failure define PaCO2 &gt; 60 mm Hg outpatient set 6 . Home mechanical ventilation ( noninvasive ventilation via tracheotomy ) except CPAP/BIPAP use solely sleepdisordered breathe 7 . Actual body weight exceed 1 kg per centimeter height 8 . Severe chronic liver disease define ChildPugh score 1215 ( Appendix A2 ) 9 . Bone marrow transplantation within last 1 year 10 . Expected duration mechanical ventilation &lt; 48 hour 11 . Decision withhold lifesustaining treatment ; except patient commit full support except cardiopulmonary resuscitation actual cardiac arrest occur 12 . Moribund patient expect survive 24 hour ; CPR provide , assess moribund status great 6 CPR conclusion 13 . Diffuse alveolar hemorrhage vasculitis 14 . Burns &gt; 70 % total body surface 15 . Unwillingness utilize ARDS Network 6 ml/kg IBW ventilation protocol 16 . Previous hypersensitivity anaphylactic reaction cisatracurium 17 . Neuromuscular condition may potentiate neuromuscular blockade and/or impair spontaneous ventilation ( Appendix A2 ) 18 . Neurologic condition undergo treatment intracranial hypertension 19 . Enrollment interventional ARDS trial direct impact neuromuscular blockade PEEP 20 . &gt; 120 hour mechanical ventilation 21 . P/F &lt; 200 mmHg time randomization ( available )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ARDS</keyword>
	<keyword>neuromuscular blocker</keyword>
	<keyword>cisatracurium</keyword>
</DOC>